• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NAFLD 大鼠模型中肝神经酰胺积累和 PI3K/Akt/mTOR 信号通路的时间依赖性变化。

Time-Dependent Changes in Hepatic Sphingolipid Accumulation and PI3K/Akt/mTOR Signaling Pathway in a Rat Model of NAFLD.

机构信息

Department of Physiology, Medical University of Bialystok, 15-089 Bialystok, Poland.

出版信息

Int J Mol Sci. 2021 Nov 19;22(22):12478. doi: 10.3390/ijms222212478.

DOI:10.3390/ijms222212478
PMID:34830360
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8618899/
Abstract

Increased lipid bioavailability in a diet favors lipid accumulation, enhancing hepatic lipotoxicity and contributing to insulin resistance (IR) development. The aim of our study was to examine time-dependent alterations in the intrahepatic content of sphingolipids and insulin signaling pathway in rats fed a high-fat diet (HFD). The experiment was conducted on male Wistar rats receiving a standard diet or HFD for five weeks. At the end of each experimental feeding week, liver sphingolipids were determined using high-performance liquid chromatography. The expression of proteins from the sphingolipid pathway and glucose transporter expression were assessed by Western blot. The content of phosphorylated form of proteins from the insulin pathway was detected by a multiplex assay kit. Our results revealed that HFD enhanced hepatic ceramide deposition by increasing the expression of selected proteins from sphingomyelin and salvage pathways in the last two weeks. Importantly, we observed a significant inhibition of Akt phosphorylation in the first week of HFD and stimulation of PTEN and mTOR phosphorylation at the end of HFD. These changes worsened the PI3K/Akt/mTOR signaling pathway. We may postulate that HFD-induced reduction in the insulin action in the time-dependent matter was exerted by excessive accumulation of sphingosine and sphinganine rather than ceramide.

摘要

饮食中脂质生物利用度的增加有利于脂质积累,增强肝毒性和导致胰岛素抵抗(IR)的发展。我们的研究目的是研究高脂饮食(HFD)喂养的大鼠肝内鞘脂含量和胰岛素信号通路的时间依赖性变化。该实验在接受标准饮食或 HFD 喂养五周的雄性 Wistar 大鼠上进行。在每个实验喂养周结束时,使用高效液相色谱法测定肝鞘脂含量。通过 Western blot 评估糖转运蛋白表达和鞘脂途径中蛋白质的表达。通过多指标测定试剂盒检测胰岛素途径中磷酸化蛋白的含量。我们的结果表明,HFD 在最后两周通过增加鞘磷脂和补救途径中选定蛋白质的表达来增强肝Cer 的沉积。重要的是,我们在 HFD 的第一周观察到 Akt 磷酸化的显著抑制,并且在 HFD 的最后阶段观察到 PTEN 和 mTOR 磷酸化的刺激。这些变化恶化了 PI3K/Akt/mTOR 信号通路。我们可以假设,HFD 诱导的胰岛素作用在时间依赖性上的降低是通过鞘氨醇和鞘氨醇的过度积累而不是 Cer 引起的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a66e/8618899/deecd45488ba/ijms-22-12478-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a66e/8618899/d7152ae84b14/ijms-22-12478-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a66e/8618899/deecd45488ba/ijms-22-12478-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a66e/8618899/d7152ae84b14/ijms-22-12478-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a66e/8618899/deecd45488ba/ijms-22-12478-g004.jpg

相似文献

1
Time-Dependent Changes in Hepatic Sphingolipid Accumulation and PI3K/Akt/mTOR Signaling Pathway in a Rat Model of NAFLD.NAFLD 大鼠模型中肝神经酰胺积累和 PI3K/Akt/mTOR 信号通路的时间依赖性变化。
Int J Mol Sci. 2021 Nov 19;22(22):12478. doi: 10.3390/ijms222212478.
2
Hepatic-Metabolic Activity of α-Lipoic Acid-Its Influence on Sphingolipid Metabolism and PI3K/Akt/mTOR Pathway in a Rat Model of Metabolic Dysfunction-Associated Steatotic Liver Disease.α-硫辛酸的肝代谢活性——对代谢功能障碍相关脂肪性肝病大鼠模型中神经酰胺代谢和 PI3K/Akt/mTOR 通路的影响。
Nutrients. 2024 May 16;16(10):1501. doi: 10.3390/nu16101501.
3
Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.康泰脂颗粒通过 AMPK/mTOR 信号通路减轻高脂饮食喂养大鼠和 HepG2 细胞的非酒精性脂肪肝病。
J Immunol Res. 2020 Aug 20;2020:3413186. doi: 10.1155/2020/3413186. eCollection 2020.
4
Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.缺乏氯离子通道蛋白2可减轻高脂饮食诱导的胰岛素抵抗和非酒精性脂肪性肝病。
Cell Physiol Biochem. 2018;45(6):2187-2198. doi: 10.1159/000488164. Epub 2018 Mar 10.
5
Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.下调 microRNA-130b-5p 可预防非酒精性脂肪性肝病小鼠模型中的脂质积累和胰岛素抵抗。
Am J Physiol Endocrinol Metab. 2020 Jul 1;319(1):E34-E42. doi: 10.1152/ajpendo.00528.2019. Epub 2020 Mar 31.
6
Mitofusin-2 ameliorates high-fat diet-induced insulin resistance in liver of rats.线粒体融合蛋白 2 可改善高脂饮食诱导的大鼠肝脏胰岛素抵抗。
World J Gastroenterol. 2013 Mar 14;19(10):1572-81. doi: 10.3748/wjg.v19.i10.1572.
7
Liquiritigenin regulates insulin sensitivity and ameliorates inflammatory responses in the nonalcoholic fatty liver by activation PI3K/AKT pathway.甘草素通过激活 PI3K/AKT 通路调节胰岛素敏感性并改善非酒精性脂肪肝的炎症反应。
Chem Biol Drug Des. 2023 Oct;102(4):793-804. doi: 10.1111/cbdd.14292. Epub 2023 Jul 16.
8
Soy protein compared with whey protein ameliorates insulin resistance by regulating lipid metabolism, AMPK/mTOR pathway and gut microbiota in high-fat diet-fed mice.大豆蛋白与乳清蛋白相比,通过调节高脂肪饮食喂养小鼠的脂质代谢、AMPK/mTOR 通路和肠道微生物群来改善胰岛素抵抗。
Food Funct. 2023 Jun 19;14(12):5752-5767. doi: 10.1039/d3fo01093g.
9
Chronic aerobic exercise improves insulin sensitivity and modulates Nrf2 and NF‑κB/IκBα pathways in the skeletal muscle of rats fed with a high fat diet.慢性有氧运动可改善高脂肪饮食喂养大鼠骨骼肌中的胰岛素敏感性,并调节 Nrf2 和 NF-κB/IκBα 通路。
Mol Med Rep. 2019 Dec;20(6):4963-4972. doi: 10.3892/mmr.2019.10787. Epub 2019 Oct 31.
10
Effective amelioration of hepatic inflammation and insulin response in high fat diet-fed rats via regulating AKT/mTOR signaling: Role of Lepidium sativum seed extracts.通过调节 AKT/mTOR 信号通路,水飞蓟素对高脂饮食喂养大鼠的肝炎症和胰岛素反应具有有效的改善作用。
J Ethnopharmacol. 2021 Feb 10;266:113439. doi: 10.1016/j.jep.2020.113439. Epub 2020 Oct 2.

引用本文的文献

1
Capsaicin and Quercitrin Maintained Lipid Homeostasis of Hyperlipidemic Mice: Serum Metabolomics and Signaling Pathways.辣椒素和槲皮苷维持高脂血症小鼠的脂质稳态:血清代谢组学与信号通路
Foods. 2024 Nov 21;13(23):3727. doi: 10.3390/foods13233727.
2
Hepatic-Metabolic Activity of α-Lipoic Acid-Its Influence on Sphingolipid Metabolism and PI3K/Akt/mTOR Pathway in a Rat Model of Metabolic Dysfunction-Associated Steatotic Liver Disease.α-硫辛酸的肝代谢活性——对代谢功能障碍相关脂肪性肝病大鼠模型中神经酰胺代谢和 PI3K/Akt/mTOR 通路的影响。
Nutrients. 2024 May 16;16(10):1501. doi: 10.3390/nu16101501.
3
Effect of Calebin-A on Critical Genes Related to NAFLD: A Protein-Protein Interaction Network and Molecular Docking Study.

本文引用的文献

1
Antioxidants Supplementation Reduces Ceramide Synthesis Improving the Cardiac Insulin Transduction Pathway in a Rodent Model of Obesity.抗氧化剂补充减少神经酰胺合成,改善肥胖啮齿动物模型的心脏胰岛素转导途径。
Nutrients. 2021 Sep 28;13(10):3413. doi: 10.3390/nu13103413.
2
Roles of Ceramides in Non-Alcoholic Fatty Liver Disease.神经酰胺在非酒精性脂肪性肝病中的作用。
J Clin Med. 2021 Feb 16;10(4):792. doi: 10.3390/jcm10040792.
3
An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease.脂质代谢与非酒精性脂肪肝病概述。
钙黄绿素A对非酒精性脂肪性肝病相关关键基因的影响:蛋白质-蛋白质相互作用网络及分子对接研究
Curr Genomics. 2024 Apr 8;25(2):120-139. doi: 10.2174/0113892029280454240214072212.
4
RPTOR blockade suppresses brain metastases of NSCLC by interfering the ceramide metabolism via hijacking YY1 binding.RPTOR 阻断通过劫持 YY1 结合干扰神经酰胺代谢抑制 NSCLC 脑转移。
J Exp Clin Cancer Res. 2024 Jan 2;43(1):1. doi: 10.1186/s13046-023-02874-z.
5
Prenatal Choline Supplement in a Maternal Obesity Model Modulates Offspring Hepatic Lipidomes.产前胆碱补充在母体肥胖模型中调节后代肝脏脂质组。
Nutrients. 2023 Feb 15;15(4):965. doi: 10.3390/nu15040965.
6
Plasma Sphingoid Base Profiles of Patients Diagnosed with Intrinsic or Idiosyncratic Drug-induced Liver Injury.诊断为固有或特发性药物性肝损伤患者的血浆神经酰胺谱。
Int J Mol Sci. 2023 Feb 3;24(3):3013. doi: 10.3390/ijms24033013.
7
Untargeted lipidomics and metagenomics reveal the mechanism of aspirin eugenol ester relieving hyperlipidemia in ApoE-/- mice.非靶向脂质组学和宏基因组学揭示阿司匹林丁香酚酯缓解ApoE -/-小鼠高脂血症的机制。
Front Nutr. 2022 Dec 19;9:1030528. doi: 10.3389/fnut.2022.1030528. eCollection 2022.
8
Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in nonalcoholic fatty liver disease.探讨神经酰胺和鞘氨醇-1-磷酸在非酒精性脂肪性肝病中的作用和发病机制。
Int J Biol Sci. 2023 Jan 1;19(1):311-330. doi: 10.7150/ijbs.78525. eCollection 2023.
9
Intracerebroventricular injection of ghrelin receptor antagonist alleviated NAFLD via improving hypothalamic insulin resistance.脑室内注射胃饥饿素受体拮抗剂通过改善下丘脑胰岛素抵抗减轻非酒精性脂肪性肝病。
Iran J Basic Med Sci. 2022 Sep;25(9):1117-1122. doi: 10.22038/IJBMS.2022.64792.14272.
10
Extracellular Vesicles in Pathogenesis and Treatment of Metabolic Associated Fatty Liver Disease.细胞外囊泡在代谢相关脂肪性肝病发病机制及治疗中的作用
Front Physiol. 2022 Jun 13;13:909518. doi: 10.3389/fphys.2022.909518. eCollection 2022.
Biomed Res Int. 2020 Jul 18;2020:4020249. doi: 10.1155/2020/4020249. eCollection 2020.
4
Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease.代谢健康和疾病中的脂肪组织、肝脏和骨骼肌中的葡萄糖转运体。
Pflugers Arch. 2020 Sep;472(9):1273-1298. doi: 10.1007/s00424-020-02417-x. Epub 2020 Jun 26.
5
Ceramide and Sphingosine 1-Phosphate in Liver Diseases.肝疾病中的神经酰胺和鞘氨醇 1-磷酸。
Mol Cells. 2020 May 31;43(5):419-430. doi: 10.14348/molcells.2020.0054.
6
MicroRNA-802 regulates hepatic insulin sensitivity and glucose metabolism.微小RNA-802调节肝脏胰岛素敏感性和葡萄糖代谢。
Int J Clin Exp Pathol. 2018 May 1;11(5):2440-2449. eCollection 2018.
7
Farnesoid X receptor activation induces the degradation of hepatotoxic 1-deoxysphingolipids in non-alcoholic fatty liver disease.法尼醇X受体激活可诱导非酒精性脂肪性肝病中肝毒性1-脱氧鞘脂的降解。
Liver Int. 2020 Apr;40(4):844-859. doi: 10.1111/liv.14340. Epub 2020 Jan 8.
8
High-Fat Feeding in Time-Dependent Manner Affects Metabolic Routes Leading to Nervonic Acid Synthesis in NAFLD.高脂喂养的时间依赖性方式会影响非酒精性脂肪性肝病中神经酸合成的代谢途径。
Int J Mol Sci. 2019 Aug 5;20(15):3829. doi: 10.3390/ijms20153829.
9
Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease.非酒精性脂肪性肝病的脂质组学生物标志物和脂毒性机制。
Free Radic Biol Med. 2019 Nov 20;144:293-309. doi: 10.1016/j.freeradbiomed.2019.05.029. Epub 2019 May 29.
10
Vitamin E alleviates non-alcoholic fatty liver disease in phosphatidylethanolamine N-methyltransferase deficient mice.维生素 E 可缓解磷脂酰乙醇胺 N-甲基转移酶缺陷型小鼠的非酒精性脂肪性肝病。
Biochim Biophys Acta Mol Basis Dis. 2019 Jan;1865(1):14-25. doi: 10.1016/j.bbadis.2018.10.010. Epub 2018 Oct 6.